Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1406 USD | -1.68% | -6.33% | -27.90% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
Financials (USD)
Sales 2022 | 0.27 | Sales 2023 | - | Capitalization | 239M |
---|---|---|---|---|---|
Net income 2022 | -211M | Net income 2023 | -79M | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M | Net Debt 2023 | 33.01M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
1 day | -2.10% | ||
1 week | -6.73% | ||
Current month | -14.27% | ||
1 month | -14.89% | ||
3 months | -15.76% | ||
6 months | -12.50% | ||
Current year | -28.21% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | Nov. 16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | Jan. 31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.1406 | -1.68% | 417 421 |
24-04-26 | 0.143 | -2.05% | 2,217,125 |
24-04-25 | 0.146 | -1.68% | 420,675 |
24-04-24 | 0.1485 | -1.00% | 648,615 |
24-04-23 | 0.15 | -0.07% | 423,580 |
Delayed Quote OTC Markets, April 29, 2024 at 11:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-28.21% | 142M | |
-2.47% | 103B | |
+1.90% | 95.28B | |
+1.46% | 22.15B | |
-15.29% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-13.20% | 16.05B | |
+4.11% | 13.68B | |
+35.69% | 12.17B |
- Stock Market
- Equities
- CYDY Stock